SCHEMBL24740666

SCHEMBL24740666

CCC1CC(N2CCCCC2)CC(CC)N1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.31
LTA4H P09960 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24265205 0.89
SCHEMBL24718638 0.76 LTA4H (0.33) HTR6LTA4H
SCHEMBL24717530 0.76 LTA4H (0.33) HTR6LTA4H
SCHEMBL10191534 0.73 LTA4H (0.34) HTR6LTA4H
SCHEMBL24700173 0.71 CYP2C9 (0.36) HTR6LTA4H
SCHEMBL24740667 0.71 KMT2A (0.31) LTA4H
Hydrochloric Acid SCHEMBL23123290 0.70 CYP2C9 (0.35) HTR6
SCHEMBL6863904 0.68
SCHEMBL12422034 0.67 FYN (0.35) HTR6LTA4H
SCHEMBL12716816 0.67 FYN (0.35) HTR6LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261120-A1 nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES THE JOHNS HOPKINS UNIVERSITY (US) 2022-12-15 WO disclosed
WO-2022261120-A1 nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES THE JOHNS HOPKINS UNIVERSITY (US) 2022-12-15 WO disclosed